Should a woman who has had her cervix removed receive both estradiol and progesterone, and does the need depend on whether her uterus is intact?

Hormone Therapy for Women Without a Cervix

A woman without a cervix who still has her uterus requires both estrogen AND progesterone, while a woman who has had a complete hysterectomy (no uterus) should receive estrogen alone without progesterone. 1

The Critical Distinction: Presence of Uterine Tissue

The need for progesterone depends entirely on whether any endometrial tissue remains, not on cervical status:

Women WITH Uterine Tissue (Cervix Removed, Uterus Intact)

• Must receive combined estrogen-progestogen therapy
• The FDA explicitly states: "When estrogen is prescribed for a postmenopausal woman with a uterus, a progestin should also be initiated to reduce the risk of endometrial cancer" 1
• Guidelines mandate progestogen administration for a minimum of 10-14 days per month in women with intact uteri 2
• Unopposed estrogen in women with a uterus causes endometrial hyperplasia in 64% of women by 36 months compared to only 6% with combined therapy 3

Women WITHOUT Uterine Tissue (Complete Hysterectomy)

• Should receive estrogen-only therapy
• "A woman without a uterus does not need progestin" 1
• Adding progestogen provides no endometrial protection benefit (no endometrium present) and may increase breast cancer risk without improving symptom relief 4

Special Consideration: Endometrial Ablation

Critical pitfall: Women who have undergone endometrial resection/ablation still require progestogen despite having minimal endometrium. Research demonstrates that after endometrial resection, unopposed estrogen caused hyperplasia in 6 patients and proliferative endometrium in 8 patients after just 1 year, while no cases occurred with combined therapy 5. This proves that residual endometrial tissue persists and requires progestogen protection.

Recommended Regimens

For women requiring combined therapy (uterus present):

• Continuous combined regimen: Low-dose estrogen with minimum 1 mg norethisterone acetate or 1.5 mg medroxyprogesterone acetate daily 6
• Sequential regimen: Progestogen for 12-15 days per month (preferred for recently menopausal women prone to breakthrough bleeding) 6
• Transdermal estrogen is preferable to avoid first-pass hepatic effects and reduce VTE risk 6, 2

For women without a uterus:

• Estrogen-only at the lowest effective dose 1
• No progestogen needed unless specific conditions exist (see below)

Rare Exceptions Requiring Progestogen Despite Hysterectomy

Add progestogen to estrogen-only therapy after hysterectomy only if:

• History of endometriosis (risk of residual endometrial implants)
• History of endometrial cancer (theoretical risk of residual disease)

These are the only clinically justified reasons to add progestogen when the uterus is absent 4.